Nomura Holdings
INO icon

Nomura Holdings’s Inovio Pharmaceuticals INO Stock Holding History

Nomura Holdings’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,987
Closed -$42.7K – 1966
2025
Q2 		$42.7K Buy
20,987
+4,116
+24% +$7.89K ﹤0.01% 1371
2025
Q1 		$27.5K Buy
+16,871
New +$33.9K ﹤0.01% 1709
2015
Q1 		– Sell
-1,393
Closed -$143K – 2012
2014
Q4 		$143K Sell
1,393
-1,968
-59% -$240K ﹤0.01% 2106
2014
Q3 		$369K Sell
3,361
-1,355
-29% -$169K ﹤0.01% 2036
2014
Q2 		$568K Buy
4,716
+834
+21% +$98.4K ﹤0.01% 1713
2014
Q1 		$623K Buy
3,882
+3,369
+657% +$484K ﹤0.01% 1673
2013
Q4 		$71K Sell
513
-630
-55% -$63K ﹤0.01% 1861
2013
Q3 		$113K Sell
1,143
-549
-32% -$46K ﹤0.01% 2044
2013
Q2 		$64K Buy
+1,692
New +$51.3K ﹤0.01% 2045

Other funds holding INO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Holdings's INO Position: Q3 2025 in Review

Nomura Holdings sold out of Inovio Pharmaceuticals (INO) in Q3 2025, closing a stake of 20,987 shares — an estimated $42.7K sold.

Nomura Holdings first reported a position in INO in Q2 2013 and held it in 9 quarters. The position peaked at $623K in Q1 2014. 99 funds tracked by Wall St. Rank hold INO as of Q3 2025.

  • Nomura Holdings reported no remaining Inovio Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Nomura Holdings sold 20,987 Inovio Pharmaceuticals shares in Q3 2025, an estimated $42.7K.
  • Nomura Holdings first reported a position in Inovio Pharmaceuticals in Q2 2013 and held it in 9 quarters.
  • Nomura Holdings's Inovio Pharmaceuticals position peaked at $623K in Q1 2014.
  • 99 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2025.

Based on Nomura Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.